Uveal Neoplasms Markets, Companies, and Investment Opportunities Analysis 2026-2030 [Yahoo! Finance]
Delcath Systems, Inc. (DCTH)
US:NASDAQ Investor Relations:
delcath.com/investors
Company Research
Source: Yahoo! Finance
Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Uveal Neoplasms Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global uveal neoplasms market has demonstrated robust growth, with projections indicating a rise from $1.14 billion in 2025 to $1.2 billion in 2026, reflecting a compound annual growth rate (CAGR) of 5.7%. This upward trend is primarily due to advancements in ophthalmic diagnostic tools, expansion of specialized eye care centers, heightened awareness of ocular tumors, and the availability of radiation-based therapies. Further growth is anticipated, with the market expected to reach $1.5 billion by 2030, at a CAGR of 5.6%. Key drivers in this forecast include increased adoption of precision medicine, heightened investment in ocular oncology research, and expanded use of immunotherapy and advanced imaging diagnostics. Trends suggest a growing emphasis on targeted treatments, early tumor detection, and personalized treatment regimens. The ris
Show less
Read more
Impact Snapshot
Event Time:
DCTH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DCTH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DCTH alerts
High impacting Delcath Systems, Inc. news events
Weekly update
A roundup of the hottest topics
DCTH
News
- Delcath Systems to Participate at the Society of Interventional Radiology 2026 MeetingBusiness Wire
- Delcath Systems publishes results from CHOPIN trial in The Lancet Oncology [Yahoo! Finance]Yahoo! Finance
- Delcath Systems Announces Publication of CHOPIN Clinical Trial Results in The Lancet Oncology [Yahoo! Finance]Yahoo! Finance
- Delcath Systems Announces Publication of CHOPIN Clinical Trial Results in The Lancet OncologyBusiness Wire
- Delcath: Fundamentals Intact, Despite Share Price Weakness [Seeking Alpha]Seeking Alpha
DCTH
Earnings
- 2/26/26 - Beat
DCTH
Sec Filings
- 4/2/26 - Form ARS
- 4/2/26 - Form DEFA14A
- 4/2/26 - Form DEF
- DCTH's page on the SEC website